BHVN Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-04-22 | Bailey Gregory | director | 1,574,568 | P-Purchase | A | 48,780 | 41.00 | 1,999,980.00 |
| 2024-04-22 | CHILDS JOHN W | director | 4,096,512 | P-Purchase | A | 97,560 | 41.00 | 3,999,960.00 |
| 2024-04-22 | CHILDS JOHN W | director | 2,254,841 | P-Purchase | A | 73,170 | 41.00 | 2,999,970.00 |
| 2024-04-22 | CHILDS JOHN W | director | 24,391 | P-Purchase | A | 24,391 | 41.00 | 1,000,031.00 |
| 2024-04-22 | Coric Vlad | director, officer: Chief Executive Officer | 1,788,417 | P-Purchase | A | 121,951 | 41.00 | 4,999,991.00 |
| 2024-04-05 | CHILDS JOHN W | director | 2,181,671 | A-Award | A | 2,091 | 0.00 | 0.00 |
| 2024-04-05 | Coric Vlad | director, officer: Chief Executive Officer | 1,666,466 | A-Award | A | 232 | 0.00 | 0.00 |
| 2024-04-05 | Coric Vlad | director, officer: Chief Executive Officer | 840,890 | A-Award | A | 231 | 0.00 | 0.00 |
| 2024-04-05 | Coric Vlad | director, officer: Chief Executive Officer | 407,213 | A-Award | A | 231 | 0.00 | 0.00 |
| 2024-03-08 | CHILDS JOHN W | director | 2,179,580 | A-Award | A | 19,412 | 0.00 | 0.00 |
| 2024-03-08 | Coric Vlad | director, officer: Chief Executive Officer | 1,666,234 | A-Award | A | 2,162 | 0.00 | 0.00 |
| 2024-03-08 | Coric Vlad | director, officer: Chief Executive Officer | 840,659 | A-Award | A | 2,155 | 0.00 | 0.00 |
| 2024-03-08 | Coric Vlad | director, officer: Chief Executive Officer | 406,982 | A-Award | A | 2,155 | 0.00 | 0.00 |
| 2024-01-08 | CHILDS JOHN W | director | 2,160,168 | J-Other | A | 48,505 | 0.00 | 0.00 |
| 2024-01-08 | Coric Vlad | director, officer: Chief Executive Officer | 1,662,431 | A-Award | A | 5,400 | 0.00 | 0.00 |
| 2024-01-08 | Coric Vlad | director, officer: Chief Executive Officer | 838,504 | A-Award | A | 5,384 | 0.00 | 0.00 |
| 2024-01-08 | Coric Vlad | director, officer: Chief Executive Officer | 404,827 | A-Award | A | 5,384 | 0.00 | 0.00 |
| 2024-01-02 | Clark George C. | officer: VP, Chief Accounting Officer | 27,500 | A-Award | A | 27,500 | 41.93 | 1,153,075.00 |
| 2024-01-02 | Car Bruce | officer: Chief Scientific Officer | 96,250 | A-Award | A | 96,250 | 41.93 | 4,035,762.00 |
| 2024-01-02 | Gentile Kimberly | officer: SVP, Clinical Operations | 96,250 | A-Award | A | 96,250 | 41.93 | 4,035,762.00 |
| 2024-01-02 | Buten Matthew | officer: Chief Financial Officer | 96,250 | A-Award | A | 96,250 | 41.93 | 4,035,762.00 |
| 2024-01-02 | Coric Vlad | director, officer: Chief Executive Officer | 275,000 | A-Award | A | 275,000 | 41.93 | 11,530,750.00 |
| 2023-12-29 | Antonijevic Irina | director | 114,000 | M-Exempt | D | 11,000 | 7.00 | 77,000.00 |
| 2023-12-29 | Antonijevic Irina | director | 13,535 | M-Exempt | A | 11,000 | 0.00 | 0.00 |
| 2023-12-29 | Antonijevic Irina | director | 2,535 | S-Sale | D | 11,000 | 41.79 | 459,662.00 |
| 2023-11-02 | Buten Matthew | officer: Chief Financial Officer | 78,750 | A-Award | A | 78,750 | 29.49 | 2,322,338.00 |
| 2023-11-02 | Coric Vlad | director, officer: Chief Executive Officer | 225,000 | A-Award | A | 225,000 | 29.49 | 6,635,250.00 |
| 2023-11-02 | Clark George C. | officer: VP, Chief Accounting Officer | 22,500 | A-Award | A | 22,500 | 29.49 | 663,525.00 |
| 2023-11-02 | Gentile Kimberly | officer: SVP, Clinical Operations | 78,750 | A-Award | A | 78,750 | 29.49 | 2,322,338.00 |
| 2023-11-02 | Car Bruce | officer: Chief Scientific Officer | 78,750 | A-Award | A | 78,750 | 29.49 | 2,322,338.00 |
| 2023-10-05 | CHILDS JOHN W | director | 3,998,952 | P-Purchase | A | 318,000 | 22.00 | 6,996,000.00 |
| 2023-10-05 | CHILDS JOHN W | director | 2,111,663 | P-Purchase | A | 136,545 | 22.00 | 3,003,990.00 |
| 2023-10-05 | Coric Vlad | director, officer: Chief Executive Officer | 1,657,031 | P-Purchase | A | 113,637 | 22.00 | 2,500,014.00 |
| 2023-10-05 | Coric Vlad | director, officer: Chief Executive Officer | 833,120 | P-Purchase | A | 340,908 | 22.00 | 7,499,976.00 |
| 2023-10-05 | Buten Matthew | officer: Chief Financial Officer | 189,380 | P-Purchase | A | 22,727 | 22.00 | 499,994.00 |
| 2023-10-04 | Bailey Gregory | director | 1,525,788 | P-Purchase | A | 17,817 | 22.57 | 402,094.00 |
| 2023-08-30 | CHILDS JOHN W | director | 1,975,118 | P-Purchase | A | 50,000 | 18.44 | 922,180.00 |
| 2023-08-04 | CHILDS JOHN W | director | 1,925,118 | P-Purchase | A | 100,000 | 19.78 | 1,978,430.00 |
| 2023-05-02 | Bailey Gregory | director | 52,906 | A-Award | A | 52,906 | 13.20 | 698,359.00 |
| 2023-05-02 | Mehta Kishan | director | 52,906 | A-Award | A | 52,906 | 13.20 | 698,359.00 |
| 2023-05-02 | GREGORY JULIA P | director | 52,906 | A-Award | A | 52,906 | 13.20 | 698,359.00 |
| 2023-05-02 | Antonijevic Irina | director | 52,906 | A-Award | A | 52,906 | 13.20 | 698,359.00 |
| 2023-05-02 | CHILDS JOHN W | director | 52,906 | A-Award | A | 52,906 | 13.20 | 698,359.00 |
| 2023-05-02 | Heffernan Michael Thomas | director | 52,906 | A-Award | A | 52,906 | 13.20 | 698,359.00 |
| 2023-05-02 | HUGIN ROBERT J | director | 52,906 | A-Award | A | 52,906 | 13.20 | 698,359.00 |
| 2022-10-25 | CHILDS JOHN W | director | 3,680,952 | P-Purchase | A | 2,380,952 | 10.50 | 24,999,996.00 |
| 2022-10-25 | CHILDS JOHN W | director | 1,825,118 | P-Purchase | A | 1,328,867 | 10.50 | 13,953,104.00 |
| 2022-11-08 | Clark George C. | director: VP, Chief Accounting Officer | None | D | 185,715 | 7.00 | 1,300,005.00 | |
| 2022-11-08 | Clark George C. | director: VP, Chief Accounting Officer | 61,285 | D | 0 | 0.00 | 0.00 | |
| 2022-11-08 | Clark George C. | director: VP, Chief Accounting Officer | 3,000 | I | 0 | 0.00 | 0.00 | |
| 2022-10-31 | Coric Vlad | director: Chief Executive Officer | 1,543,394 | P-Purchase | A | 25,800 | 15.97 | 411,995.00 |
| 2022-10-28 | Coric Vlad | director: Chief Executive Officer | 1,517,594 | P-Purchase | A | 41,930 | 14.87 | 623,352.00 |
| 2022-10-28 | Coric Vlad | director: Chief Executive Officer | 109,565 | P-Purchase | A | 100,000 | 14.82 | 1,482,420.00 |
| 2022-10-25 | Bailey Gregory | director | 1,507,971 | P-Purchase | A | 200,000 | 10.50 | 2,100,000.00 |
| 2022-10-25 | Coric Vlad | director: Chief Executive Officer | 1,475,664 | P-Purchase | A | 853,380 | 10.50 | 8,960,490.00 |
| 2022-10-25 | CHILDS JOHN W | director | 5,691,251 | P-Purchase | A | 3,900,000 | 10.50 | 40,950,000.00 |
| 2022-10-25 | Buten Matthew | director: Chief Financial Officer | 166,653 | P-Purchase | A | 142,857 | 10.50 | 1,499,998.00 |
| 2022-10-25 | GREGORY JULIA P | director | 25,665 | P-Purchase | A | 9,523 | 10.50 | 99,992.00 |
| 2022-10-03 | Coric Vlad | director: Chief Executive Officer | 569,309 | J-Other | A | 0 | 0.00 | 0.00 |
| 2022-10-03 | HUGIN ROBERT J | director | 12,959 | F-InKind | D | 12,959 | 7.50 | 97,192.00 |
| 2022-10-03 | Heffernan Michael Thomas | director | 15,178 | F-InKind | D | 9,699 | 7.50 | 72,742.00 |
| 2022-10-05 | Coric Vlad | director, officer: Chief Executive Officer | 492,212 | P-Purchase | A | 54,329 | 11.83 | 642,614.00 |
| 2022-10-05 | Coric Vlad | director, officer: Chief Executive Officer | 437,883 | P-Purchase | A | 80,907 | 10.83 | 875,843.00 |
| 2022-10-05 | Coric Vlad | director, officer: Chief Executive Officer | 399,443 | P-Purchase | A | 2,100 | 12.35 | 25,928.00 |
| 2022-10-05 | Coric Vlad | director, officer: Chief Executive Officer | 397,343 | P-Purchase | A | 52,523 | 11.79 | 619,162.00 |
| 2022-10-05 | Coric Vlad | director, officer: Chief Executive Officer | 356,976 | P-Purchase | A | 34,515 | 9.90 | 341,843.00 |
| 2022-10-05 | Coric Vlad | director, officer: Chief Executive Officer | 344,820 | P-Purchase | A | 80,606 | 10.82 | 871,907.00 |
| 2022-10-05 | Coric Vlad | director, officer: Chief Executive Officer | 322,461 | P-Purchase | A | 73,331 | 8.82 | 647,029.00 |
| 2022-10-05 | Coric Vlad | director, officer: Chief Executive Officer | 264,214 | P-Purchase | A | 34,459 | 9.89 | 340,968.00 |
| 2022-10-05 | Coric Vlad | director, officer: Chief Executive Officer | 229,755 | P-Purchase | A | 73,005 | 8.82 | 644,130.00 |
| 2022-10-05 | CHILDS JOHN W | director | 1,791,251 | P-Purchase | A | 32,841 | 9.70 | 318,403.00 |
| 2022-10-05 | CHILDS JOHN W | director | 1,758,410 | P-Purchase | A | 241,300 | 8.88 | 2,142,768.00 |
| 2022-10-03 | Coric Vlad | director, officer: Chief Executive Officer | 622,284 | J-Other | A | 46,025 | 0.00 | 0.00 |
| 2022-10-03 | Coric Vlad | director, officer: Chief Executive Officer | 249,130 | J-Other | A | 249,130 | 0.00 | 0.00 |
| 2022-10-03 | Coric Vlad | director, officer: Chief Executive Officer | 156,750 | J-Other | A | 156,750 | 0.00 | 0.00 |
| 2022-10-03 | Coric Vlad | director, officer: Chief Executive Officer | 9,565 | J-Other | A | 9,565 | 0.00 | 0.00 |
| 2022-10-03 | CHILDS JOHN W | director | 1,517,110 | J-Other | A | 1,512,500 | 0.00 | 0.00 |
| 2022-10-03 | CHILDS JOHN W | director | 5,000 | J-Other | A | 5,000 | 0.00 | 0.00 |
| 2022-10-03 | Heffernan Michael Thomas | director | 125,000 | A-Award | A | 125,000 | 7.00 | 875,000.00 |
| 2022-10-03 | Heffernan Michael Thomas | director | 24,877 | M-Exempt | A | 13,100 | 2.40 | 31,440.00 |
| 2022-10-03 | Heffernan Michael Thomas | director | 19,370 | F-InKind | D | 5,507 | 7.50 | 41,302.00 |
| 2022-10-03 | Heffernan Michael Thomas | director | 13,100 | J-Other | A | 13,100 | 2.40 | 31,440.00 |
| 2022-10-03 | Heffernan Michael Thomas | director | 11,777 | M-Exempt | A | 5,998 | 3.56 | 21,353.00 |
| 2022-10-03 | Heffernan Michael Thomas | director | 5,998 | J-Other | A | 5,998 | 3.56 | 21,353.00 |
| 2022-10-03 | Heffernan Michael Thomas | director | 5,779 | M-Exempt | A | 4,119 | 4.84 | 19,936.00 |
| 2022-10-03 | Heffernan Michael Thomas | director | 4,119 | J-Other | A | 4,119 | 4.84 | 19,936.00 |
| 2022-10-03 | Heffernan Michael Thomas | director | 1,660 | J-Other | A | 1,660 | 0.00 | 0.00 |
| 2022-10-03 | Heffernan Michael Thomas | director | 0 | M-Exempt | D | 5,998 | 3.56 | 21,353.00 |
| 2022-10-03 | Heffernan Michael Thomas | director | 0 | M-Exempt | D | 13,100 | 2.40 | 31,440.00 |
| 2022-10-03 | Heffernan Michael Thomas | director | 0 | M-Exempt | D | 4,119 | 4.84 | 19,936.00 |
| 2022-10-03 | Gentile Kimberly | officer: SVP, Clinical Operations | 300,000 | A-Award | A | 300,000 | 7.00 | 2,100,000.00 |
| 2022-10-03 | Gentile Kimberly | officer: SVP, Clinical Operations | 133,461 | M-Exempt | A | 12,500 | 0.54 | 6,750.00 |
| 2022-10-03 | Gentile Kimberly | officer: SVP, Clinical Operations | 120,961 | M-Exempt | A | 4,500 | 1.86 | 8,370.00 |
| 2022-10-03 | Gentile Kimberly | officer: SVP, Clinical Operations | 116,461 | M-Exempt | A | 20,716 | 1.03 | 21,337.00 |
| 2022-10-03 | Gentile Kimberly | officer: SVP, Clinical Operations | 95,969 | F-InKind | D | 37,492 | 7.00 | 262,444.00 |
| 2022-10-03 | Gentile Kimberly | officer: SVP, Clinical Operations | 95,745 | M-Exempt | A | 295 | 1.03 | 303.90 |
| 2022-10-03 | Gentile Kimberly | officer: SVP, Clinical Operations | 95,450 | M-Exempt | A | 1,542 | 1.61 | 2,483.00 |
| 2022-10-03 | Gentile Kimberly | officer: SVP, Clinical Operations | 93,908 | M-Exempt | A | 30,958 | 1.61 | 49,842.00 |
| 2022-10-03 | Gentile Kimberly | officer: SVP, Clinical Operations | 62,950 | M-Exempt | A | 3,000 | 2.52 | 7,560.00 |
| 2022-10-03 | Gentile Kimberly | officer: SVP, Clinical Operations | 59,950 | M-Exempt | A | 14,000 | 2.84 | 39,760.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
